GOLDMAN SACHS GROUP INC - SIGILON THERAPEUTICS INC ownership

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$26,599
+349.6%
28,598
+69.2%
0.00%
Q4 2022$5,916
-34.3%
16,902
-1.9%
0.00%
Q3 2022$9,000
-35.7%
17,227
+1.2%
0.00%
Q2 2022$14,000
-36.4%
17,030
+12.4%
0.00%
Q1 2022$22,000
-85.7%
15,157
-72.7%
0.00%
Q4 2021$154,000
-43.0%
55,526
+16.0%
0.00%
Q3 2021$270,000
-25.0%
47,860
+42.6%
0.00%
Q2 2021$360,000
-18.0%
33,552
+70.8%
0.00%
Q1 2021$439,000
-73.9%
19,649
-43.9%
0.00%
Q4 2020$1,681,00035,0000.00%
Other shareholders
SIGILON THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 10,370,369$58,592,0000.61%
HARBOURVEST PARTNERS LLC 740,740$4,185,0000.39%
Monashee Investment Management LLC 317,460$1,794,0000.33%
SOUNDMARK WEALTH MANAGEMENT, LLC 50,555$286,0000.10%
Artal Group S.A. 276,000$1,559,0000.04%
Choate Investment Advisors 66,666$377,0000.02%
CANADA PENSION PLAN INVESTMENT BOARD 1,485,185$8,391,0000.01%
STATE OF WISCONSIN INVESTMENT BOARD 509,629$2,879,0000.01%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 229,500$1,297,0000.00%
Woodline Partners LP 34,200$193,0000.00%
View complete list of SIGILON THERAPEUTICS INC shareholders